New virtual melanoma nurse, an Australian-first for regional and rural Australians

The AOMA-funded virtual melanoma nurse is a new specialist telehealth service to support patients with ocular melanoma in remote and regional areas of Australia.

Professor H. Peter Soyer, Director of The University of Queensland Diamantina Institute, with melanoma screening system, VECTRA

Professor H. Peter Soyer is focused on improving the early detection of skin cancer through a nationwide melanoma screening program.

New MASC Trials CEO, Cheryl-Ann Hawkins

MASC Trials is pleased to announce the appointment of Cheryl-Ann Hawkins as Chief Executive.

AOMA Summit 2021

Building on the highly successful inaugural summit in 2019, The Australasian Ocular Melanoma Alliance (AOMA) Summit returns in 2021.

Uveal Melanoma Registry launched in Australia

MASC Trials opens the Australian arm of the first global patient registry for uveal melanoma.

A mother applies sunscreen to her on the beach
Libby Patton, Former CEO of MASC Trials

The board and staff of MASC Trials thank Libby Paton for her 12 years of service as Chief Executive Officer.

Women applies sunscreen, as summer turns up heat on skin cancer risk

New data shows there has been a 73.6% reduction in referrals for melanoma between April and June 2020 when compared to the same period over the past three years, with COVID-19 restrictions suspected to be a major cause of people putting off appointments.

Aileen Boyd-Squires, Former Chief Executive of MASC Trials

“It is a privilege to lead this important organisation,” says Aileen Boyd-Suires, Chief Executive of Melanoma and Skin Cancer Trials.

IMAT Clinical Trial

Join Dr Wen Xu, Prof. Gerald Fogarty and Jonathan Pincus for a discussion about the I-MAT clinical trial, which aims to improve the management of early stage Merkel Cell Carcinoma.